Aclaris Therapeutics (ACRS) Net Margin Growth (1y) (2018 - 2026)
Aclaris Therapeutics (ACRS) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn | -60,608.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,608.00 |
| Dec 31, 2025 | -124,272.00 |
| Sep 30, 2025 | -35,940.00 |
| Jun 30, 2025 | -64,718.00 |
| Mar 31, 2025 | -54,395.00 |
| Dec 31, 2024 | -116,501.00 |
| Sep 30, 2024 | 13,257.00 |
| Jun 30, 2024 | 167,207.00 |
| Mar 31, 2024 | 62,283.00 |
| Dec 31, 2023 | 273,924.00 |
| Sep 30, 2023 | -16,355.00 |
| Jun 30, 2023 | 1,847.00 |
| Mar 31, 2023 | 126,636.00 |
| Dec 31, 2022 | 957,130.00 |
| Sep 30, 2022 | 212,572.00 |
| Jun 30, 2022 | -15,756.00 |
| Mar 31, 2022 | 77,717.00 |
| Dec 31, 2021 | -1.23 Mn |
| Jun 30, 2021 | -194,616.00 |
| Mar 31, 2021 | -337,480.00 |